CSIMarket



Dyne Therapeutics Inc   (DYN)
Other Ticker:  
 
 

DYN's EPS from Cont. Operations Growth by Quarter and Year

Dyne Therapeutics Inc 's EPS from Cont. Operations results by quarter and year




DYN EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1.00 0.73 -1.96
III Quarter September - -0.83 -2.01 4.00
II Quarter June - -0.58 -0.78 -1.11
I Quarter March -0.69 -0.50 -0.89 -1.81
FY   -0.69 -2.91 -2.95 -0.88



DYN EPS from Cont. Operations first quarter 2022 Y/Y Growth Comment
Dyne Therapeutics Inc in the first quarter 2022 recorded EPS loss from Cont. Operations of $ -0.69 .

According to the results reported in the first quarter 2022, Dyne Therapeutics Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Dyne Therapeutics Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2022.




DYN EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Dyne Therapeutics Inc 's first quarter 2022 EPS from Cont. Operations $ -0.69 DYN's Income Statement
Dyne Therapeutics Inc 's first quarter 2021 EPS from Cont. Operations $ -0.50 Quarterly DYN's Income Statement
New: More DYN's historic EPS from Cont. Operations Growth >>


DYN EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Dyne Therapeutics Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DYN's I. Quarter Q/Q EPS from Cont. Operations Comment
Although Dyne Therapeutics Inc in the I. Quarter 2022 admitted EPS loss from Cont. Operations of $ -0.69 , some analyst mentioned, that those numbers are improvement in contrast to the -1.00 in the forth quarter.

Within Biotechnology & Pharmaceuticals industry Dyne Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Dyne Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DYN's I. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Dyne Therapeutics Inc in the I. Quarter 2022 showed EPS loss from Cont. Operations of $ -0.69 , it should be mentioned, that this point to improvement relative to the -1.00 in the forth quarter.

Within Biotechnology & Pharmaceuticals industry Dyne Therapeutics Inc achieved highest sequential EPS from Cont. Operations growth. While Dyne Therapeutics Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Dyne Therapeutics Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -3.10 $ -2.91 $ -1.18 $ -2.36 $ -2.56
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Dyne Therapeutics Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Mar 31 2022 period.
The situation is getting worse as the cumulative EPS loss from Cont. Operations is getting bigger from $ -2.91 in TTM ending quarter Dec 31 2021 and $ -1 for the twelve months ending in the quarter Mar 31 2021 Mario Morales mentioned.

Dyne Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Dyne Therapeutics Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Mar 31 2022 period.
The business is getting worse as the cumulative EPS loss from Cont. Operations is getting bigger from $ -2.91 in TTM ending quarter Dec 31 2021 and $ -1 for the twelve months ending in the quarter a year ago Mario Morales mentioned.

Dyne Therapeutics Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
DYN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for DYN's Competitors
EPS from Cont. Operations Growth for Dyne Therapeutics Inc 's Suppliers
EPS from Cont. Operations Growth for DYN's Customers

You may also want to know
DYN's Annual Growth Rates DYN's Profitability Ratios DYN's Asset Turnover Ratio DYN's Dividend Growth
DYN's Roe DYN's Valuation Ratios DYN's Financial Strength Ratios DYN's Dividend Payout Ratio
DYN's Roa DYN's Inventory Turnover Ratio DYN's Growth Rates DYN's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2022
Becton Dickinson And Company58.95%$ 58.947 
Repligen Corp57.41%$ 57.407 
Iqvia Holdings Inc 54.05%$ 54.054 
Conmed Corporation50.00%$ 50.000 
Charles River Laboratories International inc 49.59%$ 49.593 
Phibro Animal Health Corp46.67%$ 46.667 
Prestige Consumer Healthcare Inc 45.71%$ 45.708 
Medpace Holdings Inc 44.63%$ 44.628 
Tenet Healthcare Corp41.76%$ 41.758 
Eli Lilly And Company41.61%$ 41.611 
Abbott Laboratories38.00%$ 38.000 
Abcellera Biologics Inc 37.21%$ 37.209 
Merck and Co Inc 34.92%$ 34.921 
The Pennant Group Inc 33.33%$ 33.333 
Bio techne Corp31.36%$ 31.356 
Abbvie Inc 26.00%$ 26.000 
Co diagnostics Inc.25.00%$ 25.000 
Syneos Health Inc 21.62%$ 21.622 
Mettler Toledo International Inc19.19%$ 19.189 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BRZE's Profile

Stock Price

BRZE's Financials

Business Description

Fundamentals

Charts & Quotes

BRZE's News

Suppliers

BRZE's Competitors

Customers & Markets

Economic Indicators

BRZE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071